Jörg J. Jacoby

1.7k total citations
16 papers, 1.4k citations indexed

About

Jörg J. Jacoby is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jörg J. Jacoby has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Jörg J. Jacoby's work include Fungal and yeast genetics research (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jörg J. Jacoby is often cited by papers focused on Fungal and yeast genetics research (5 papers), Lung Cancer Treatments and Mutations (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jörg J. Jacoby collaborates with scholars based in United States, Germany and China. Jörg J. Jacoby's co-authors include Jürgen J. Heinisch, Hans‐Peter Schmitz, Anja Lorberg, Roy S. Herbst, Ignacio I. Wistuba, Suzanne E. Davis, Juri G. Gelovani, Michael Schneider, Qian Gao and Lan Ji and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Biotechnology.

In The Last Decade

Jörg J. Jacoby

16 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jörg J. Jacoby United States 14 908 296 189 175 164 16 1.4k
Marc Bracke Belgium 23 825 0.9× 289 1.0× 185 1.0× 116 0.7× 164 1.0× 46 1.6k
Xiaoping Wu China 22 864 1.0× 185 0.6× 137 0.7× 237 1.4× 83 0.5× 81 1.4k
Alina Grzanka Poland 20 881 1.0× 257 0.9× 257 1.4× 148 0.8× 72 0.4× 142 1.6k
Yanling Zhang China 25 1.2k 1.3× 262 0.9× 79 0.4× 289 1.7× 73 0.4× 98 1.7k
Xiaoqing Wu China 29 1.7k 1.8× 346 1.2× 90 0.5× 591 3.4× 160 1.0× 111 2.5k
Xiaoling Zhou China 24 909 1.0× 249 0.8× 191 1.0× 174 1.0× 115 0.7× 83 1.6k
Kazuishi Kubota Japan 20 1.1k 1.2× 229 0.8× 212 1.1× 139 0.8× 37 0.2× 43 2.0k
David C. Montrose United States 23 794 0.9× 248 0.8× 81 0.4× 256 1.5× 33 0.2× 40 1.5k
Jean C. Ingram United Kingdom 18 755 0.8× 547 1.8× 88 0.5× 151 0.9× 59 0.4× 24 1.6k
Weimin Tang United States 20 530 0.6× 204 0.7× 32 0.2× 119 0.7× 80 0.5× 50 1.2k

Countries citing papers authored by Jörg J. Jacoby

Since Specialization
Citations

This map shows the geographic impact of Jörg J. Jacoby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg J. Jacoby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg J. Jacoby more than expected).

Fields of papers citing papers by Jörg J. Jacoby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jörg J. Jacoby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg J. Jacoby. The network helps show where Jörg J. Jacoby may publish in the future.

Co-authorship network of co-authors of Jörg J. Jacoby

This figure shows the co-authorship network connecting the top 25 collaborators of Jörg J. Jacoby. A scholar is included among the top collaborators of Jörg J. Jacoby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jörg J. Jacoby. Jörg J. Jacoby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
3.
Wang, Yueqiang, et al.. (2017). Effects of Medium- and Long-Chain Triacylglycerols on Lipid Metabolism and Gut Microbiota Composition in C57BL/6J Mice. Journal of Agricultural and Food Chemistry. 65(31). 6599–6607. 70 indexed citations
4.
Isobe, Takeshi, Amir Onn, Daniel Morgensztern, et al.. (2013). Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(2). 140–146. 26 indexed citations
5.
Takahashi, Osamu, Ritsuko Komaki, Paul D. Smith, et al.. (2012). Combined MEK and VEGFR Inhibition in Orthotopic Human Lung Cancer Models Results in Enhanced Inhibition of Tumor Angiogenesis, Growth, and Metastasis. Clinical Cancer Research. 18(6). 1641–1654. 49 indexed citations
6.
Wistuba, Ignacio I., Juri G. Gelovani, Jörg J. Jacoby, Suzanne E. Davis, & Roy S. Herbst. (2011). Methodological and practical challenges for personalized cancer therapies. Nature Reviews Clinical Oncology. 8(3). 135–141. 143 indexed citations
7.
Cascone, Tina, Matthew H. Herynk, Li Xu, et al.. (2011). Upregulated stromal EGFR and vascular remodeling in mouse xenograft models of angiogenesis inhibitor–resistant human lung adenocarcinoma. Journal of Clinical Investigation. 121(4). 1313–1328. 123 indexed citations
8.
Jacoby, Jörg J., Baruch Erez, Ryan Williams, et al.. (2010). Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice. Journal of Thoracic Oncology. 5(7). 940–949. 67 indexed citations
9.
Jacoby, Jörg J., Baruch Erez, Osamu Takahashi, et al.. (2010). Abstract 3632: Addition of the HIF-1α inhibitor PX-478 enhances the therapeutic efficacy of EGFR inhibitors in an orthotopic human lung adenocarcinoma model. Cancer Research. 70(8_Supplement). 3632–3632. 1 indexed citations
10.
Meuillet, Emmanuelle J., Zuohe Song, Robert Lemos, et al.. (2010). Molecular Pharmacology and Antitumor Activity of PHT-427, a Novel Akt/Phosphatidylinositide-Dependent Protein Kinase 1 Pleckstrin Homology Domain Inhibitor. Molecular Cancer Therapeutics. 9(3). 706–717. 66 indexed citations
11.
Jacoby, Jörg J., April Kalinowski, Mu-Gen Liu, et al.. (2003). Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proceedings of the National Academy of Sciences. 100(22). 12929–12934. 295 indexed citations
12.
Jacoby, Jörg J., et al.. (2000). Use of G-protein fusions to monitor integral membrane protein–protein interactions in yeast. Nature Biotechnology. 18(10). 1075–1079. 55 indexed citations
13.
Heinisch, Jürgen J., Anja Lorberg, Hans‐Peter Schmitz, & Jörg J. Jacoby. (1999). The protein kinase C‐mediated MAP kinase pathway involved in the maintenance of cellular integrity in Saccharomyces cerevisiae. Molecular Microbiology. 32(4). 671–680. 284 indexed citations
14.
Jacoby, Jörg J., et al.. (1999). Characterization of KLBCK1, encoding a MAP kinase kinase kinase of Kluyveromyces lactis. Journal of Molecular Biology. 288(3). 337–352. 13 indexed citations
15.
Jacoby, Jörg J., et al.. (1998). A screen for upstream components of the yeast protein kinase C signal transduction pathway identifies the product of the SLG1 gene. Molecular and General Genetics MGG. 258(1-2). 148–155. 91 indexed citations
16.
Jacoby, Jörg J., Hans‐Peter Schmitz, & Jürgen J. Heinisch. (1997). Mutants affected in the putative diacylglycerol binding site of yeast protein kinase C. FEBS Letters. 417(2). 219–222. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026